Which of the following patients is eligible for Mounjaro (ti…
Which of the following patients is eligible for Mounjaro (tirzepatide) for treatment of type 2 diabetes according to NICE technology appraisal guidance TA924? You may refer to the following reference source.Overview | Tirzepatide for treating type 2 diabetes | Guidance | NICE BMI HbA1c Oral antidiabetic regimen a. 28 kg/m2 62 mmol/mol Metformin, canagliflozin, gliclazide b. 32 kg/m2 70 mmol/mol Gliclazide, dapagliflozin c. 35 kg/m2 58 mmol/mol Metformin, gliclazide, sitaglipin d. 38 kg/m2 50 mmol/mol Lifestyle controlled e. 40 kg/m2 46 mmol/mol Metformin
Read DetailsWhich of the following results would confirm a diagnosis of…
Which of the following results would confirm a diagnosis of diabetic ketoacidosis? Blood ketone Blood glucose Serum bicarbonate A 4.8 mmol/L 5 mmol/L 16 mmol/L B 3.2 mmol/L 15 mmol/L 14.8 mmol/L C 2.9 mmol/L 8 mmol/L 16.2 mmol/L D 2.8 mmol/L 10 mmol/L 17 mmol/L E 1.8 mmol/L 11 mmol/L 14.2 mmol/L
Read Details